← Leaderboards
Anne-Marie Wills
Brigham And Women'S Hospital
$10,585,717
Attributed
$38,443,586
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $19.7M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,443,586 · 4
By mechanism
R01$30,281,212 · 1
UF1$5,174,076 · 1
R44$2,546,364 · 1
U10$441,934 · 1
Top collaborators
- Alexander Y. Pantelyat4 shared
- Ashkan Vaziri4 shared
- Adam L Boxer2 shared
- Irene Litvan2 shared
- Julio Cesar Rojas-Martinez2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Andrew Budson$4,171,044
- Bethany Hedt-Gauthier$3,339,535
- Ofer Pasternak$5,629,700
- Sylvain Bouix$7,506,811
- Richard D. Urman$1,746,202
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsDisease ProgressionAlzheimer&AposParkinson DiseaseAffectQuality Of LifeDisabilityMotorFutureParticipantFundingUnited States National Institutes Of HealthRecruitNeuroprotectionCognitive FunctionNovel TherapeuticsSafetyEffective TherapyProtocols DocumentationCessation Of LifePilot ProjectsNeurodegenerative DisordersProgressive Supranuclear PalsyRandomized
Grant awards (11)
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)$14,499,067
R01 · FY2025 · AG
Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies$5,174,076
UF1 · FY2025 · AG
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)$15,782,145
R01 · FY2024 · AG
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes$50,000
R44 · FY2024 · AG
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes$1,246,364
R44 · FY2023 · AG
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes$1,250,000
R44 · FY2022 · AG
Continuation of NET-PD Trials$13,388
U10 · FY2014 · NS · contact PI
Continuation of NET-PD Trials$89,971
U10 · FY2013 · NS · contact PI
Clinical Trial to Demonstrate Neuroprotection in Parkinson's Disease$190,118
U10 · FY2011 · NS · contact PI
Clinical Trial to Demonstrate Neuroprotection in Parkinson's Disease$105,857
U10 · FY2010 · NS · contact PI
Clinical Trial to Demonstrate Neuroprotection in Parkinson's Disease$42,600
U10 · FY2010 · NS · contact PI